Abstract
The association between type 2 diabetes mellitus (T2DM) and systemic inflammation may increase platelet reactivity and the accelerated development of vascular disease. Platelets are able to modulate the function of immune cells via the direct release of growth factors and pro-inflammatory chemokines through the production of microvesicles. The microvesicles trigger a transcellular delivery system of bioactive molecules to other cells acting as vectors in the exchange of biological information. Here, we consider the influence of platelets and platelet-derived microvesicles on cells of the immune system and the implications in the pathogenesis of T2DM.
Keywords: Platelets, microvesicles, immune, effectors, diabetes, inflammation.
Current Vascular Pharmacology
Title:Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes
Volume: 15 Issue: 3
Author(s): Nancy Cortez-Espinosa, Laura Perez-Campos Mayoral*, Eduardo Perez-Campos, Hector Alejandro Cabrera Fuentes, Eduardo Perez-Campos Mayoral, Ruth Martínez-Cruz, Socorro Pina Canseco, Gabriel Mayoral Andrade, Margarito Martinez Cruz, Itandehui Gallegos Velasco and Pedro Hernandez Cruz
Affiliation:
- Department of Investigation Medicine-UNAM-UABJO, Faculty of School of Medicine, UABJO University, CP 60120, Oaxaca,Mexico
Keywords: Platelets, microvesicles, immune, effectors, diabetes, inflammation.
Abstract: The association between type 2 diabetes mellitus (T2DM) and systemic inflammation may increase platelet reactivity and the accelerated development of vascular disease. Platelets are able to modulate the function of immune cells via the direct release of growth factors and pro-inflammatory chemokines through the production of microvesicles. The microvesicles trigger a transcellular delivery system of bioactive molecules to other cells acting as vectors in the exchange of biological information. Here, we consider the influence of platelets and platelet-derived microvesicles on cells of the immune system and the implications in the pathogenesis of T2DM.
Export Options
About this article
Cite this article as:
Cortez-Espinosa Nancy, Mayoral Perez-Campos Laura*, Perez-Campos Eduardo, Cabrera Fuentes Alejandro Hector, Mayoral Perez-Campos Eduardo, Martínez-Cruz Ruth, Canseco Pina Socorro, Andrade Mayoral Gabriel, Cruz Martinez Margarito, Velasco Gallegos Itandehui and Cruz Hernandez Pedro, Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes, Current Vascular Pharmacology 2017; 15 (3) . https://dx.doi.org/10.2174/1570161115666170126130309
DOI https://dx.doi.org/10.2174/1570161115666170126130309 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Retinal Arteriolar Central Reflection by APOE Genotype
Current Alzheimer Research Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Human Platelets Express Authentic CB1 and CB2 Receptors
Current Neurovascular Research Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design Literature Review: Use of Family History for Primary Paediatric Care as the Next Step Towards use of Genomics in Healthcare
Current Pediatric Reviews Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Antenatal Maternal Antidepressants Drugs Affect S100B Concentrations in Fetal-Maternal Biological Fluids
CNS & Neurological Disorders - Drug Targets The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Respiratory Gas Exchange During Exercise in Children with Congenital Heart Disease: Methodology and Clinical Concepts
Current Respiratory Medicine Reviews The Accuracy of Self-Reported Hypertension: A Systematic Review and Meta-Analysis
Current Hypertension Reviews Editorial (Thematic Issue: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics)
Current Vascular Pharmacology Pharmacotherapy of Obesity - Benefit, Bias and Hyperbole
Current Medicinal Chemistry Leptin and Inflammation
Current Immunology Reviews (Discontinued) Adrenergic Action in Breast Cancer
Current Cancer Therapy Reviews Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design New Approaches to Develop Anti-Staphylococcal Agents
Current Medicinal Chemistry - Anti-Infective Agents Targeting Mitochondria for Cardiac Protection
Current Drug Targets Novel Insights Into Lp(a) Physiology and Pathogenicity: More Questions Than Answers?
Cardiovascular & Hematological Disorders-Drug Targets